Copyright
©The Author(s) 2025.
World J Gastroenterol. Sep 7, 2025; 31(33): 109811
Published online Sep 7, 2025. doi: 10.3748/wjg.v31.i33.109811
Published online Sep 7, 2025. doi: 10.3748/wjg.v31.i33.109811
Table 1 Studies evaluating transperineal ultrasound in pediatric perianal Crohn’s disease
Ref. | Patients (n) | Main findings | Concordance or accuracy vs MRI |
Hwang et al[11], 2014 | 43 | TPUS feasible in all; 47% with active fistula, 19% with abscess; well tolerated | No MRI comparison; pain severity correlated with activity |
Lee et al[12], 2018 | 38 | TPUS sensitivity 76% (fistula), 56% (abscess); better concordance with MRI than colonoscopy | κ = 0.296 for fistula, 0.624 for abscess |
Jung et al[13], 2022 | 29 | TPUS detected 80% of fistulas; excellent PPV (95%) and specificity (93%) for response | κ = 0.486; sensitivity 63%, accuracy 73% |
Jung et al[13], 2022 (MRI/TPUS) analysis | 56 fistulas analyzed | TPUS more likely to miss superficial/thin tracts; intersphincteric better detected | Detection correlated with thickness (P = 0.009); 80.4% of MRI fistulas seen on TPUS |
Table 2 Summary of studies comparing transperineal ultrasound with magnetic resonance imaging or surgical findings in perianal Crohn’s disease and inflammatory bowel disease
Ref. | No. of patients | Patient characteristics | Concordance rate (TPUS vs MRI or surgery) | Main findings |
Maconi et al[2], 2013 | 59 | Adults with CD, prospective | κ = 0.78 (fistulae classification) | TPUS sensitivity 94%, PPV 93%; less accurate for extrasphincteric/suprasphincteric tracts and deep abscesses |
Bor et al[16], 2016 | 23 | Adults with complicated CD | Not specified | TPUS 100% sensitivity for fistulae and abscesses; outperformed MRI and TRUS |
Jung et al[13], 2022 | 29 | Pediatric CD on biologics | κ = 0.49 | TPUS had high specificity (93%) and PPV (95%) for assessing treatment response vs MRI |
Lee et al[12], 2018 | 38 | Pediatric CD with PACD | κ = 0.30-0.62 | TPUS better concordance with MRI than colonoscopy; sensitivity 76% for fistulae, 56% for abscesses |
Wedemeyer et al[18], 2004 | 25 | Adults with active PACD | κ > 0.83 | TPUS detected 90% of fistulas and 86% of abscesses; comparable to MRI; especially useful in anal stenosis |
Terracciano et al[17], 2016 | 28 | IBD patients | Sensitivity 100% for RVF and superficial abscess; κ = 0.34 for deep abscess | TPUS highly concordant with MRI for Parks (κ = 0.67) and AGA (κ = 0.83) classifications; superior for RVF and superficial abscesses |
Table 3 Studies evaluating transperineal ultrasound in ulcerative colitis
Ref. | No. of patients | Patient characteristics | Concordance rate | Main findings |
Sagami et al[6], 2020 | 84 | UC patients undergoing induction therapy; correlation with endoscopy and histology | BWT ≥ 4 mm correlated with MES > 1; sensitivity > 90% | TPUS can predict mucosal and histological healing with high accuracy |
Sagami et al[19], 2022 | 100 | UC patients on induction therapy; early TPUS response at week 1 vs remission at week 8 | ΔBWT at week 1 predictive of week 8 remission (AUC = 0.75) | ΔBWT ≥ 1 mm at 1 week predicted treatment success; more accurate than CRP/FC |
Greeve et al[21], 2024 | 8 | Pregnant women with ulcerative proctitis | Feasibility and acceptability in pregnancy; no adverse events | TPUS feasible and safe during all pregnancy trimesters, including 3rd trimester |
Tokushima et al[20], 2024 | 131 | Pediatric patients with UC (MES 0-3) and non-IBD proctitis | RWT > 4.5 mm and MSWC positive had 100% sensitivity and specificity for active UC vs proctitis | TPUS with mSMI can differentiate UC from non-IBD proctitis with accuracy similar to colonoscopy |
Pal et al[3], 2025 | 142 | Adults with UC (proctitis, proctosigmoiditis, extensive colitis); compared TPUS, TAS, and EUS | TPUS AUC 0.73 (endoscopic remission), 0.66 (histologic remission) | TPUS moderately accurate for distal disease; TAS+TPUS improved diagnostic value but still inferior to EUS |
- Citation: Pal P, Mateen MA, Pooja K, Gupta R, Tandan M, Reddy DN. Transperineal ultrasound: Role in inflammatory bowel disease management. World J Gastroenterol 2025; 31(33): 109811
- URL: https://www.wjgnet.com/1007-9327/full/v31/i33/109811.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i33.109811